Patients generally seem happy with their GLP-1 injections
A: Foundayo is approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition
Macro tracking simply means paying attention to the nutritional components of the food youre eating, specifically the protein, carbs, and fats
The effect of GLP-1RA use was compared with three commonly used antihyperglycemics: dipeptidyl peptidase 4 (DPP4) inhibitors, sulfonylureas, and sodium-glucose cotransporter-2 (SGLT2) inhibitors
We forecast one to two GLP-1 launches annually starting in 2026, with the first oral entrant expected by 2027
1 Until April 15, 2026, the 4 mg dose will be available to patients for a price of $149 per month then will jump to $199 per month, with the highest doses of the Wegovy pill set to be available for $299